XML 52 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
The Business - Cell Therapy Development and Manufacturing (Details) - USD ($)
$ in Millions
1 Months Ended
Oct. 02, 2017
Dec. 31, 2017
May 31, 2017
Mar. 11, 2016
Subsidiary or Equity Method Investee [Line Items]        
Revenue from grants $ 1.9 $ 1.9 $ 5.7  
Equity Method Investment, Ownership Percentage       19.90%
Hitachi America [Member]        
Subsidiary or Equity Method Investee [Line Items]        
Equity Method Investment, Ownership Percentage       21.00%